Virtus Biotech Clinical Trials Etf: Historic Quarter Change, Added
No data for this tab of Virtus Biotech Clinical Trials Etf on this site yet.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI) | United States | $7.434B | 36.11% |
| Direxion Daily S&P Biotech Bull 3X Shares (LABU) | United States | $0.519B | 33.82% |
| Invesco Dorsey Wright Healthcare Momentum ETF (PTH) | United States | $0.121B | 31.40% |
| ALPS Medical Breakthroughs ETF (SBIO) | United States | $0.138B | 29.54% |
| Principal Healthcare Innovators ETF (BTEC) | 20.60% | ||
| Invesco Dorsey Wright SmallCap Momentum ETF (DWAS) | United States | $0.386B | 20.55% |
| abrdn Life Sciences Investors (HQL) | United States | 20.09% | |
| Range Cancer Therapeutics ETF (CNCR) | 19.29% | ||
| Tema Oncology ETF (CANC) | United States | $0.160B | 18.52% |
| abrdn Healthcare Investors (HQH) | United States | 16.85% |